The chaperone-like protein 14-3-3η interacts with human α-synuclein aggregation intermediates rerouting the amyloidogenic pathway and reducing α-synuclein cellular toxicity (Q24298721)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	The chaperone-like protein 14-3-3η interacts with human α-synuclein aggregation intermediates rerouting the amyloidogenic pathway and reducing α-synuclein cellular toxicity	scientific article

Statements

scholarly article

0 references

The chaperone-like protein 14-3-3η interacts with human α-synuclein aggregation intermediates rerouting the amyloidogenic pathway and reducing α-synuclein cellular toxicity (English)

0 references

molecular chaperones

0 references

Synuclein alpha

1 reference

GOA release 2020-03-11

identical protein binding

1 reference

GOA release 2020-03-11

1 reference

based on heuristic

inferred from title

8

object named as

Elisa Greggio

author given names

Elisa

author last names

Greggio

1 reference

PubMed publication ID

9 December 2023

7

object named as

Elisa Belluzzi

author given names

Elisa

author last names

Belluzzi

1 reference

PubMed publication ID

9 December 2023

object named as

Dhruv Kumar

2

author given names

Dhruv

author last names

Kumar

1 reference

PubMed publication ID

9 December 2023

Nicoletta Plotegher

object named as

Nicoletta Plotegher

1

author given names

Nicoletta

author last names

Plotegher

1 reference

PubMed publication ID

9 December 2023

Francesca Munari

object named as

Francesca Munari

5

author given names

Francesca

author last names

Munari

1 reference

PubMed publication ID

9 December 2023

object named as

Laura Tosatto

6

author given names

Laura

author last names

Tosatto

1 reference

PubMed publication ID

9 December 2023

Stefano Capaldi

object named as

Stefano Capaldi

10

author given names

Stefano

author last names

Capaldi

1 reference

PubMed publication ID

9 December 2023

Isabella Tessari

object named as

Isabella Tessari

3

author given names

Isabella

author last names

Tessari

1 reference

PubMed publication ID

9 December 2023

object named as

Marco Brucale

4

author given names

Marco

author last names

Brucale

1 reference

PubMed publication ID

9 December 2023

object named as

Hugo L Monaco

13

author given names

Hugo L

author last names

Monaco

1 reference

PubMed publication ID

9 December 2023

object named as

Luigi Bubacco

15

author given names

Luigi

author last names

Bubacco

1 reference

PubMed publication ID

9 December 2023

12

object named as

Stefano Mammi

author given names

Stefano

author last names

Mammi

1 reference

PubMed publication ID

9 December 2023

9

object named as

Marco Bisaglia

author given names

Marco

author last names

Bisaglia

1 reference

PubMed publication ID

9 December 2023

11

object named as

Daniel Aioanei

author given names

Daniel

author last names

Aioanei

1 reference

PubMed publication ID

9 December 2023

author name string

Bruno Samo

14

author given names

Bruno

author last names

Samo

1 reference

PubMed publication ID

9 December 2023

language of work or name

0 references

publication date

1 November 2014

0 references

Human Molecular Genetics

0 references

23

0 references

21

0 references

5615-29

0 references

Epidemiology of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU275

21 January 2018

Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU275

21 January 2018

Monogenic Parkinson's disease and parkinsonism: clinical phenotypes and frequencies of known mutations

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU275

21 January 2018

α-Synuclein mutations cluster around a putative protein loop

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU275

21 January 2018

α-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson's disease and multiple system atrophy?

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU275

21 January 2018

The many faces of alpha-synuclein mutations

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU275

21 January 2018

α-Synuclein in Lewy bodies

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU275

21 January 2018

Biophysical groundwork as a hinge to unravel the biology of α-synuclein aggregation and toxicity

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU275

21 January 2018

Intrinsically disordered proteins from A to Z.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU275

21 January 2018

Understanding protein non-folding.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU275

21 January 2018

Expanding the proteome: disordered and alternatively folded proteins

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU275

21 January 2018

The N-Terminus of the Intrinsically Disordered Protein α-Synuclein Triggers Membrane Binding and Helix Folding

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU275

21 January 2018

α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU275

21 January 2018

A soluble α-synuclein construct forms a dynamic tetramer

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU275

21 January 2018

α-Synuclein in central nervous system and from erythrocytes, mammalian cells, and Escherichia coli exists predominantly as disordered monomer

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU275

21 January 2018

α-Synuclein inhibits intersynaptic vesicle mobility and maintains recycling-pool homeostasis

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU275

21 January 2018

The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU275

21 January 2018

Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU275

21 January 2018

Observation of spatial propagation of amyloid assembly from single nuclei

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU275

21 January 2018

alpha-synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU275

21 January 2018

Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU275

21 January 2018

In vivo demonstration that alpha-synuclein oligomers are toxic

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU275

21 January 2018

Alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU275

21 January 2018

Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU275

21 January 2018

Pathogenesis of Parkinson's disease: emerging role of molecular chaperones

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU275

21 January 2018

Heat shock protein 70 inhibits alpha-synuclein fibril formation via preferential binding to prefibrillar species

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU275

21 January 2018

The interaction of alphaB-crystallin with mature alpha-synuclein amyloid fibrils inhibits their elongation

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU275

21 January 2018

DJ-1 is a redox-dependent molecular chaperone that inhibits alpha-synuclein aggregate formation

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU275

21 January 2018

Countering amyloid polymorphism and drug resistance with minimal drug cocktails

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU275

21 January 2018

Small heat shock proteins potentiate amyloid dissolution by protein disaggregases from yeast and humans

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU275

21 January 2018

14-3-3 proteins in the nervous system

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU275

21 January 2018

Intrinsic disorder is a key characteristic in partners that bind 14-3-3 proteins.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU275

21 January 2018

Structural basis for protein-protein interactions in the 14-3-3 protein family

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU275

21 January 2018

C-terminal binding: an expanded repertoire and function of 14-3-3 proteins

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU275

21 January 2018

14-3-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localization

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU275

21 January 2018

14-3-3eta is a novel regulator of parkin ubiquitin ligase

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU275

21 January 2018

14-3-3 proteins in Lewy bodies in Parkinson disease and diffuse Lewy body disease brains

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU275

21 January 2018

Structure-oriented review of 14-3-3 protein isoforms in geriatric neuroscience

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU275

21 January 2018

alpha-Synuclein is colocalized with 14-3-3 and synphilin-1 in A53T transgenic mice

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU275

21 January 2018

Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU275

21 January 2018

Differential neuroprotective effects of 14-3-3 proteins in models of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU275

21 January 2018

Sensitive fluorescence polarization technique for rapid screening of alpha-synuclein oligomerization/fibrillization inhibitors.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU275

21 January 2018

A novel, high-efficiency cellular model of fibrillar alpha-synuclein inclusions and the examination of mutations that inhibit amyloid formation

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU275

21 January 2018

Seeded aggregation and toxicity of {alpha}-synuclein and tau: cellular models of neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU275

21 January 2018

Specification of 14-3-3 proteins in Lewy bodies

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU275

21 January 2018

14-3-3 protein is a component of Lewy bodies in Parkinson's disease-mutation analysis and association studies of 14-3-3 eta.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU275

21 January 2018

A53T-alpha-synuclein-overexpression in the mouse nigrostriatal pathway leads to early increase of 14-3-3 epsilon and late increase of GFAP

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU275

21 January 2018

Role of different regions of alpha-synuclein in the assembly of fibrils.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU275

21 January 2018

Low-resolution structure of a vesicle disrupting α-synuclein oligomer that accumulates during fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU275

21 January 2018

Direct observation of the interconversion of normal and toxic forms of α-synuclein

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU275

21 January 2018

Interactions between Hsp70 and the hydrophobic core of alpha-synuclein inhibit fibril assembly

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU275

21 January 2018

Characterization of hydrophobic residue requirements for alpha-synuclein fibrillization

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU275

21 January 2018

Confocal fluorescence anisotropy and FRAP imaging of α-synuclein amyloid aggregates in living cells

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU275

21 January 2018

Formation of toxic oligomeric alpha-synuclein species in living cells

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU275

21 January 2018

Number and Brightness analysis of alpha-synuclein oligomerization and the associated mitochondrial morphology alterations in live cells

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU275

21 January 2018

Amyloid-like aggregates sequester numerous metastable proteins with essential cellular functions

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU275

21 January 2018

Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU275

21 January 2018

Exogenous α-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU275

21 January 2018

14-3-3zeta is indispensable for aggregate formation of polyglutamine-expanded huntingtin protein

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU275

21 January 2018

A new method for purification of recombinant human alpha-synuclein in Escherichia coli.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU275

21 January 2018

Structural properties of pore-forming oligomers of alpha-synuclein

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU275

21 January 2018

Molecular composition of sub-stoichiometrically labeled α-synuclein oligomers determined by single-molecule photobleaching

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU275

7 January 2021

based on heuristic

inferred from DOI database lookup

Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU275

7 January 2021

based on heuristic

inferred from DOI database lookup

Atomic force microscopy under controlled conditions reveals structure of C-terminal region of α-synuclein in amyloid fibrils

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU275

7 January 2021

based on heuristic

inferred from DOI database lookup

Structural insights on physiological functions and pathological effects of alpha-synuclein.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU275

7 January 2021

based on heuristic

inferred from DOI database lookup

Probable participation of 14-3-3 in tau protein oligomerization and aggregation.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU275

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24298721&oldid=2026656614"